Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Core Insights - Doximity Inc reported better-than-expected earnings for Q1, with earnings of 36 cents per share, surpassing the analyst consensus estimate of 30 cents per share [1] - The company achieved quarterly sales of $145.913 million, exceeding the analyst consensus estimate of $139.705 million [1] - Doximity raised its FY2026 sales guidance from a range of $619 million-$631 million to $628 million-$636 million [1] Company Performance - The CEO of Doximity highlighted strong profit growth and record engagement across their newsfeed, workflow, and AI products, with the AI suite growing 5x year-over-year [2] - Over 630,000 prescribers utilized Doximity's workflow tools to enhance efficiency and patient service [2] - Following the earnings announcement, Doximity shares increased by 10.3%, trading at $64.55 [2] Analyst Ratings - Needham analyst Ryan MacDonald maintained a Buy rating on Doximity and raised the price target from $67 to $75 [7] - Wells Fargo analyst Stan Berenshteyn maintained an Equal-Weight rating and increased the price target from $62 to $65 [7]